June 2024 - Opening of Comparison N Temporarily Paused

Following a change in the STAMPEDE2 trial funding arrangements, the trial has temporarily paused opening the Comparison N (Niraparib) part of the trial. Ongoing updates to the STAMPEDE2 website will reflect this development. Should Comparison N be reinstated in the future, further notifications will be communicated to sites and posted here on the trial website.